Article Type
Changed
Mon, 07/23/2018 - 14:22
Display Headline
Should all patients with chronic kidney disease receive an EPO-type drug?
Article PDF
Author and Disclosure Information

Jeffrey S. Berns, MD
Associate Professor, Renal, Electrolyte, and Hypertension Division, University of Pennsylvania School of Medicine, Philadelphia

Address: Jeffrey S. Berns, MD, Penn Presbyterian Medical Center, Medical Office Building #240, 41 North 39th Street, Philadelphia, PA 19104; e-mail [email protected]

Issue
Cleveland Clinic Journal of Medicine - 73(3)
Publications
Topics
Page Number
298-300
Sections
Author and Disclosure Information

Jeffrey S. Berns, MD
Associate Professor, Renal, Electrolyte, and Hypertension Division, University of Pennsylvania School of Medicine, Philadelphia

Address: Jeffrey S. Berns, MD, Penn Presbyterian Medical Center, Medical Office Building #240, 41 North 39th Street, Philadelphia, PA 19104; e-mail [email protected]

Author and Disclosure Information

Jeffrey S. Berns, MD
Associate Professor, Renal, Electrolyte, and Hypertension Division, University of Pennsylvania School of Medicine, Philadelphia

Address: Jeffrey S. Berns, MD, Penn Presbyterian Medical Center, Medical Office Building #240, 41 North 39th Street, Philadelphia, PA 19104; e-mail [email protected]

Article PDF
Article PDF
Related Articles
Issue
Cleveland Clinic Journal of Medicine - 73(3)
Issue
Cleveland Clinic Journal of Medicine - 73(3)
Page Number
298-300
Page Number
298-300
Publications
Publications
Topics
Article Type
Display Headline
Should all patients with chronic kidney disease receive an EPO-type drug?
Display Headline
Should all patients with chronic kidney disease receive an EPO-type drug?
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media